DigestSea
Commercial- Indications
- Animal digestive health
Company intelligence / Profile preview
Olmix develops biosourced solutions based on marine algae and natural extracts for sustainable agriculture. Its patented technologies such as SEALICA® have demonstrated improved crop yields in field trials. The company’s portfolio includes commercialized biostimulants for plants and natural feed additives that improve animal health by reducing mycotoxins and supporting immunity. Recent acquisitions have expanded its capabilities in foliar biostimulants and seed treatments.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Olmix Group.